We advise PostNL on sale of German business operations to Quantum

International law firm Bird & Bird recently advised Dutch Post, PostNL on the sale of its German business operations “Postcon” to Quantum Capital Partners. Postcon is the second biggest mail provider in Germany.

The exact purchase price has not been disclosed. The transaction is subject to a number of conditions, including merger clearance, and is expected to close before the end of 2019.

Postcon processes more than 1 billion letters per year and has a market share of around 10% in Germany. The company employs about 5,300 direct and indirect employees.

The Bird & Bird team was led by Dusseldorf Partner Stefanie Orttmann, who together with Partner Alfred Herda and Associates Jan Medele, Christoph Meves and Jennifer Neff (all Corporate / M & A, Dusseldorf), Partner Catharina Klumpp and Associates Benjamin Karcher and Christian Wirtz, (all Labor Law Dusseldorf), Partner Matthias Lang (Dusseldorf), Partner Alexander Csaki (Munich), Counsel Martin Conrads (Hamburg) and Associates Johannes Werschmann and Tobias Büscher (both Dusseldorf), all Public Law, Partner Lennart Schüßler, Counsel Lea Mackert, and Associate Natallia Karniyevich (all Commercial / Data Protection, Dusseldorf), Partner Dirk Barcaba (Real Estate, Frankfurt), Counsel Constantin Eikel and Associate Julia Präger (both IP / Trademark Law, Dusseldorf), Senior Counsel Martin Jäger, Counsel Stephan Waldheim and Associates Marcio Da Silva Lima and Heike Lesch (all antitrust law, Dusseldorf) advised on the deal.

News & Deals

More News & Deals
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More